REPLY
We appreciate the opportunity to reply to the letter sent by Dr. d'Udekem and colleagues concerning the article we recently published in JACC.
Although we are grateful for their interest in our work, we would like to address the issues they have raised. First, their statement that ". . . all patients operated on . . . showed neither clinical improvement nor regression of ventricular volumes after reoperation . . . " is incorrect. As our article clearly stated, most of our symptomatic patients had a significant clinical improvement postoperatively (24% NYHA class Ն III preoperatively vs. 0% postoperatively, p Ͻ 0.001) (1). Unfortunately, this could not be confirmed objectively (the same mean duration of exercise and external workload was achieved both pre-and postoperatively). Furthermore, although the mean right ventricular volume and function did not improve postoperatively, about one-third of our patients did show such improvement as depicted in Figures 1, 2 and 3 of our article (1) . Unfortunately, the relatively small number of patients made it impossible to determine which of the many factors analyzed favored such a response. Finally, we disagree with the statement that "the . . . effect of this [bulky bioprosthesis] . . . is to further increase the size of the right ventricular cavity" . . . and impede contraction of the pulmonary infundibulum by virtue of its extensive transannular patching. They are correct that we do enlarge the outflow tract to accommodate as large a prosthesis as possible, but the patch to do this is largely from the annulus distally. Proximal to the annulus, the patch extends into the infundibulum a distance of 10 to 15 mm. We do not believe that a 10 to 15 mm incision below the pulmonary annulus would have an important impact on right ventricular volume and function. We do agree, however, that any incision in the right ventricle should be avoided or minimized as much as possible in order to potentiate maximal postoperative functional recovery.
The issue of pulmonary valve replacement in adults late after repair of tetralogy of Fallot remains a controversial one and we again thank Dr. d'Udekem and colleagues for their interest in our work. 
Judith Therrien, MD
The Sir Mortimer B Davis-Jewish General Hospital 3755 Chemin de la Cote-Sainte Catherine Room E
A Real Smoker's Paradox
The article by van Domburg et al. (1) in the September issue of the Journal presented detailed but not unexpected findings with regard to the hazards of cigarette smoking. However, I wonder whether the authors are aware that in Figure 2 of their paper, there is a graph which implies that the survival rate of cigarette smokers who quit after their bypass operation is significantly better than those who continue to smoke, but also significantly better than those who have never smoked. One would have to conclude from this data that the best chances of survival are among those who smoke up until the time of their surgery and then quit, rather than never to smoke at all. This would truly be a smoker's paradox if in fact it is correct! I would appreciate some explanation from the authors.
David Shander, MD
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REPLY
We appreciate the comments of Dr. Shander regarding our recent article in JACC (1). In his comments he concluded that "the best chances of survival are among those who smoke up until the time of their surgery and then quit rather than never to smoke at all." We have proven that patients who quit smoking after bypass surgery are significantly better off than those who continue to smoke. However, in our study we only compared the patients who quit smoking with patients who continued smoking. Because of its irrelevancy, we did not compare the patients who quit smoking with patients who did not smoke. Furthermore, we did not use the term "never smoked" but used the term "nonsmoking." We did not distinguish between patients who have never smoked and exsmokers (patients who had stopped smoking before the time of surgery), and we combined these two groups into one nonsmokers' group at the time of surgery. The smoking habits at the time of surgery did not influence survival during the follow-up period. This smoker's paradox is partly explained by the difference in baseline characteristics such as an age difference (smokers were four years younger than nonsmokers). Another explanation could be selection bias, as many smokers tend to die of fatal myocardial infarctions before they have the chance to undergo coronary bypass surgery (2). Finally, the survival rates of the nonsmokers were probably positively influenced by the ex-smokers. In conclusion, the worse condition of the nonsmokers as compared with the smokers at the
